| Literature DB >> 26370230 |
Guoqi Wang1,2, Zhi Mao1, Lihai Zhang1, Licheng Zhang1, Yanpeng Zhao1, Peng Yin1,3, Ling Gao4, Peifu Tang5, Hongjun Kang6.
Abstract
PURPOSE: This meta-analysis compared the clinical outcomes of locking plate with intramedullary nail in the treatment of displaced proximal humeral fractures.Entities:
Mesh:
Year: 2015 PMID: 26370230 PMCID: PMC4570456 DOI: 10.1186/s13018-015-0242-4
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Flow diagram shows the process of literature selection
Characteristics of included studies
| Studies | Intervention | Mean age (year) (LP | Number (LP | Percent female (%) | Follow-up (month) | Rate of follow-up | Type of study | Diagnosis characteristics | |
|---|---|---|---|---|---|---|---|---|---|
| LP | IN | ||||||||
| Von et al. 2014 [ | Locking plate osteosynthesis (PHILOS®, Synthes, Umkirch, Deutschland; VariAX®, Stryker, Duisburg, Deutschland) | Intramedullary nailing (T2-PHN®, Stryker, Duisburg, Deutschland) | 61 (35–84) | 28 | 36.1 | 38–82 | 100 | Retrospective | Displaced three- or four-part fractures |
| Lekic et al. 2011 [ | Locking plates osteosynthesis (Stryker, Mahwah, NJ; Accumed, Trenton, NJ) | Intramedullary nailing (Synthes, Paoli, PA) | 59 (21–81) | 12 | 83.3 | 3–46 | 92 | Retrospective | Displaced two-part fractures |
| Konrad et al. 2012 [ | Plate (proximal humeral interlocking system (PHILOS)/locking proximal humerus plate (LPHP)) | Nail (proximal humeral nail (PHN)) | 65.4 (15.6) | 153 |
| 3–12 | 84.4 | Prospective | Displaced three-part fractures |
| Trepat et al. 2011 [ | PHILOS plate | NHP-T2 nail | 68.3 (17.3) | 14 | 72.7 | 6–12 | 82.8 | Retrospective | Displaced two-part fractures |
| Zhu et al. 2011 [ | Locking plate osteosynthesis (LPHP; Synthes; PHILOS; Synthes) | Locking intramedullary nail (PHN; Synthes, Oberdorf, Switzerland) | 50.5 (19.9) | 26 | 69.2 | 12–36 | 89.0 | RCT | Displaced two-part fractures |
| Smejkal et al. 2011 [ | PHILOS plate (Synthes, Switzerland) | Intramedullary nails (Zifko method) | 61 (21–81) | 28 | 81.8 | 2–18 | 90.2 | RCT | Displaced two or three-part fractures |
| Matziolis et al. 2010 [ | Locking compression plate (PHP) | Zifko nails | 54.8 (22–72) | 11 | 63.6 | 36 | 100 | Retrospective | Displaced two-part fractures |
| Gradl et al. 2009 [ | Locking Proximal Humerus Plate (Mathys AG, Bettlach, Switzerland) | Sliding stable interlocking nail (Targon PH; B. Braun-Aesculap, Tuttlingen, Germany) | 63 (16) | 76 | 68.4 | 12 | 74.8 | Prospective | Displaced two-, three-, or four-part fractures |
LP locking plate, IN intramedullary nail
Fig. 2The methodological quality of the RCTs. Risk of bias summary. “+” means low risk; “?” means unclear risk; “-” means high risk
MINORS appraisal scores for the included retrospective studies
| Study | Methodologic itemsa | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| Von et al. 2014 | 2 | 1 | 0 | 2 | 0 | 2 | 2 | 0 | 1 | 2 | 2 | 2 | 16 |
| Lekic et al. 2012 | 2 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | 2 | 14 |
| Konrad et al. 2012 | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 1 | 2 | 2 | 2 | 18 |
| Trepat et al. 2011 | 2 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 2 | 2 | 2 | 16 |
| Matziolis et al. 2010 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 1 | 2 | 2 | 2 | 17 |
| Gradl et al. 2009 | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 1 | 2 | 2 | 2 | 18 |
aMethodologic items are as follows: (1) a clearly stated aim; (2) inclusion of consecutive patients; (3) prospective collection of data; (4) endpoints appropriate to the aim of the study; (5) unbiased assessment of the study endpoint; (6) follow-up period appropriate to the aim of the study; (7) loss to follow-up, which is less than 5 %; (8) prospective calculation of the study size; (9) an adequate control group; (10) contemporary groups; (11) baseline equivalence of groups; and (12) adequate statistical analyses. The items are scored as “0” (not reported), “1” (reported but inadequate) or “2” (reported and adequate). The global ideal score for comparative studies is 24 [18]
Fig. 3Meta-analysis of Constant scores: subgroup analyses. LP locking plate, IN intramedullary nail
Fig. 4Forest plot for total complication rate between locking plate group and intramedullary nail group. LP locking plate, IN intramedullary nail
Complications reported
| Outcomes | No. of trials | No. of patients | Plate group | Nail group | RR (95 % CI) |
|
|
|
|---|---|---|---|---|---|---|---|---|
| Additional surgery | 8 [ | 615 | 48 of 348 | 37 of 267 | 0.98 (0.65, 1.47) | 0.92 | 11 | 0.34 |
| Osteonecrosis | 4 [ | 408 | 6 of 252 | 5 of 156 | 0.93 (0.32, 2.75) | 0.90 | 0 | 0.66 |
| Infection | 4 [ | 360 | 6 of 220 | 1 of 140 | 2.09 (0.49, 8.90) | 0.32 | 0 | 0.81 |
| Nonunion | 3 [ | 295 | 7 of 195 | 1 of 100 | 2.24 (0.50,10.14) | 0.29 | 0 | 0.41 |
| Penetration | 6 [ | 521 | 25 of 309 | 10 of 212 | 1.59 (0.79, 3.18) | 0.19 | 25 | 0.25 |
| Impingement | 3 [ | 295 | 8 of 195 | 6 of 100 | 0.89 (0.11, 7.02) | 0.91 | 55 | 0.11 |
| Redisplacement of fracture | 2 [ | 224 | 5 of 104 | 8 of 120 | 0.80 (0.02, 39.17) | 0.91 | 79 | 0.03 |
CI confidence interval, RR risk ratio
Sensitivity analyses based on various exclusion criteria for total complication
| Excluded trial | No. of trials | No. of patients | Plate group | Nail group | RR (95 % CI) |
|
|
|
|---|---|---|---|---|---|---|---|---|
| Zhu 2011 | 7 [ | 564 | 99 of 322 | 68 of 242 | 1.06 (0.80, 1.41) | 0.68 | 5 | 0.39 |
| Smejkal 2011 | 7 [ | 560 | 96 of 320 | 60 of 240 | 1.05 (0.69, 1.60) | 0.80 | 41 | 0.12 |
| Gradl 2009 | 7 [ | 463 | 85 of 272 | 52 of 191 | 1.03 (0.67, 1.58) | 0.91 | 39 | 0.13 |
| Matziolis 2010 | 7 [ | 593 | 103 of 337 | 65 of 256 | 1.08 (0.73,1.60) | 0.70 | 41 | 0.12 |
| Trepat 2011 | 7 [ | 586 | 102 of 334 | 59 of 252 | 1.22 (0.90, 1.65) | 0.20 | 5 | 0.39 |
| Lekic 2012 | 7 [ | 592 | 103 of 336 | 64 of 256 | 1.12 (0.76, 1.64) | 0.56 | 37 | 0.15 |
| Konrad 2012 | 7 [ | 404 | 59 of 195 | 57 of 209 | 0.99 (0.66, 1.47) | 0.95 | 30 | 0.20 |
| Von 2014 | 7 [ | 543 | 102 of 320 | 58 of 223 | 1.13 (0.77, 1.65) | 0.53 | 36 | 0.15 |
CI confidence interval, RR risk ratio
Sensitivity analyses based on various exclusion criteria for total complication
| Excluded trial | No. of trials | MD (95 % CI) |
|
|
|
|---|---|---|---|---|---|
| Smejkal 2011 | 4 [ | 0.06 (−3.72, 3.84) | 0.97 | 44 | 0.15 |
| Zhu 2011 | 4 [ | −1.76 (−4.51, 0.99) | 0.21 | 0 | 0.77 |
| Gradl 2009 | 4 [ | 0.52 (−2.96, 4.00) | 0.77 | 33 | 0.22 |
| Matziolis 2010 | 4 [ | −0.39 (−3.58, 2.80) | 0.81 | 37 | 0.19 |
| Konrad 2012 | 4 [ | 0.85 (−2.90, 4.60) | 0.66 | 22 | 0.28 |
CI confidence interval, MD mean difference
Fig. 5Funnel plot for publication bias